Delivery Order SPE2DB25D3006-SPE2DB25FXKKC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,899.43 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100 count) on August 11, 2025, with ultimate completion by August 12, 2025. This firm fixed price delivery order carries no set-aside designation and was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a $5,978.22 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $47,631.00 for 100 tablets of Concerta ER 54 mg on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price, competitively awarded contract (with no set-aside designation) represents a pharmaceutical supply delivery under the company's existing DLA contract vehicle. The medication will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) valued at $3,319.06. This is a firm fixed-price delivery order with no set-aside designation, executed competitively. The order is scheduled for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among...
- The Defense Logistics Agency (DLA) awarded a $1,010.88 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on August 28, 2025, with completion due by August 29, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg with a ceiling value of $1,910.48 under a firm fixed-price contract. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery against an existing contract vehicle. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $2,444.15. This competitively awarded, firm fixed-price delivery order is not set aside for any particular business category and carries an ultimate completion date of August 25, 2025. The contract is executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,690.75 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) under a firm fixed price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Concerta ER 18 mg tablets in quantities of 100 units, with a ceiling value of $36,401.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The order is scheduled for completion by August 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $3,724.82 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery against AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKKCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,475.54 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER 18 mg tablets (100-count package). This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract demonstrates AmerisourceBergen's proven capability to fulfill federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/11/25 |